NCT00818415View on ClinicalTrials.gov

Naproxen Sodium ER Pharmacokinetic Study

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Pain
Interventions
DRUG

Naproxen sodium ER (BAYH6689)

Extented release Naproxen sodium (660mg) administered once a day

DRUG

Commercial Naproxen (Aleve, BAYH6689)

Immediate release Commercial Aleve (220mg) administered in a two ( 440 mg) plus one (220mg) dosing regime, 660 mg daily

Trial Locations (1)

78744

Austin

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00818415 - Naproxen Sodium ER Pharmacokinetic Study | Biotech Hunter | Biotech Hunter